Cytegrity™
Cytegrity™ lentivirus producer system now available
We are excited to announce that the Cytegrity™ proprietary stable production system from CSL is now available for Genezen customers, cutting timelines to 3 months for delivery of a viable, stable lentiviral producer cell line.
Accelerating
Accelerating the pace to clinic and beyond
As a viral vector CDMO, we break through barriers in cell and gene therapy by delivering high-quality, cost-effective and precise development, GMP viral vector manufacturing and testing services.

Accelerating the pace to clinic and beyond

As a viral vector CDMO, we break through barriers in cell and gene therapy by delivering high-quality, cost-effective and precise development, GMP viral vector manufacturing and testing services.

Scroll Down

Our Solutions

Solutions to propel your therapies forward

Whether you have a process defined or need guidance to identify the best path forward, we have the flexibility to support our customers wherever they are in their viral vector development journey. Keeping your growth front of mind, we tailor our solutions with the intent to get you to and through trial as quickly as possible.

Connecting great discoveries with expert capabilities

We have the capacity, scalability, and reproducibility to accelerate your therapy. Learn more about our services.

Watch video

What makes Genezen the right choice?

Client-centric guidance paired with complete viral vector development capabilities and GMP manufacturing capacity make us the perfect partner.

Production Capacity

Production Capacity

Time is of the essence when manufacturing viral vectors. We are continuously expanding to provide the essential and phased capacity that our customers need.

Scalability

Scalability

Everything we do is focused on accelerating your therapy to market. Our expertise and growth mindset help you move forward with confidence.

Experienced Partnership

Experienced Partnership

Our talented team and the added value of our world-class partnerships provide the essential experience to support lentivirus production.

State-of-the-art facility available

Retrovirus and lentivirus production availability

Specialists in retrovirus and lentivirus production, we can accelerate your therapy to commercialization and help you deliver life-changing therapeutics to patients.

Our new 75,000 square-foot facility in the fast-growing gene therapy hub of Indianapolis provides you with the essential capacity and latest technologies dedicated to the aseptic manufacture of lentiviral and retroviral vectors.

Find out more about our facilitiesStart a conversation

Explore Careers at Genezen

Do you have a passion to promote scientific advancement? Are you hungry to grow alongside and help shape a fast-developing, science-led CDMO? You may be a perfect fit for Genezen and we’d love to hear from you.

Find the right jobLife at Genezen

Experience our new branding in

00
D
:
00
H
:
00
M
:
00
S

Ring in the

Fresh new look. Same trusted partner.

Experience our new branding in

00
D
:
00
H
:
00
M
:
00
S